[Depressive symptoms and negative symptoms during XXXX ].

@entity1 @entity308 @entity12269 @entity4270 @entity910 @entity2845 @entity2026 @entity161 @entity21
Taking into account the wellknown frequency of @entity21 in @entity161 and the rare studies about their evolution, several questions can be raised: How do these different symptoms move? Are there specific characters of each of them? First, stability of negative symptoms evaluated by the Scale for the Assessment of Negative Symptoms ( @entity12269 ) was studied among 57 @entity161 @entity1 at admission and at discharge. The course of negative symptoms was compared to that of @entity308 (Montgomery et Asberg Depression Rating Scale) and @entity2845 symptoms (Extrapyramidal Symptom Rating Scale). All the subscores of the @entity12269 decreased significantly but 4 items belonging to the affective flattening subscale and one item belonging to the @entity2026 subscale did not vary significantly, showing the necessity of taking into account the individual items of the @entity12269 rather than the subscale scores to evaluate the course of negative symptoms. Changes in all the @entity12269 subscores except the @entity2026 and @entity4270 subscores were associated with variations in scores of other scales. Correlations between the changes of negative symptoms and the changes of depressive symptoms showed the necessity to do more specific scales, for example, scales for @entity308 in @entity161 . Langlois-Th  ry et al. (1994) evaluated among 53 @entity161 @entity1 stabilized with neuroleptic treatment, depressive symptomatology with Echelle de Ralentissement D  pressif (ERD, Widl  cher, 1983) and MADRS, negative symptomatology (Positive and Negative Syndrome Scale) and @entity910 (ESRS), to determinate whether ERD composed of 3 subscores (motor, ideic and subjective) could be able to evaluate the depressive symptomatology, independently of the measures of negative and @entity2845 symptomatology.(ABSTRACT TRUNCATED AT 250 WORDS)
